190 related articles for article (PubMed ID: 35065281)
1. Influence of a 12-month supervised, intensive resistance, aerobic and impact exercise intervention on muscle strength in prostate cancer patients undergoing anti-hormone therapy: Study protocol for the randomized, controlled Burgdorf study.
Reimer N; Hafke R; Wrensch M; Horst P; Bloch W; Hahn T; Kirchhoff A; Kluck KL; Stein J; Baumann FT
Contemp Clin Trials; 2022 Mar; 114():106685. PubMed ID: 35065281
[TBL] [Abstract][Full Text] [Related]
2. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
[TBL] [Abstract][Full Text] [Related]
3. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
[TBL] [Abstract][Full Text] [Related]
4. Effects of Different Exercise Modalities on Fatigue in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Year-long Randomised Controlled Trial.
Taaffe DR; Newton RU; Spry N; Joseph D; Chambers SK; Gardiner RA; Wall BA; Cormie P; Bolam KA; Galvão DA
Eur Urol; 2017 Aug; 72(2):293-299. PubMed ID: 28249801
[TBL] [Abstract][Full Text] [Related]
5. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
[TBL] [Abstract][Full Text] [Related]
6. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
[TBL] [Abstract][Full Text] [Related]
7. Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation.
McNaught E; Reale S; Bourke L; Brown JE; Collinson M; Day F; Hewison J; Farrin AJ; Ibeggazene S; Innes AQ; Mason E; Meads D; Scope A; Taylor C; Taylor SJ; Turner RR; Rosario DJ;
Trials; 2024 Apr; 25(1):257. PubMed ID: 38610058
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
[TBL] [Abstract][Full Text] [Related]
9. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN
BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Exercise on Body Composition and Physical Performance in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (ADT): A Narrative Synthesis.
Logan L; Toohey K; Kavanagh PS; Paterson C; McKune AJ
Semin Oncol Nurs; 2020 Oct; 36(5):151067. PubMed ID: 33010982
[TBL] [Abstract][Full Text] [Related]
11. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
[TBL] [Abstract][Full Text] [Related]
12. Moderators of resistance-based exercise programs' effect on sarcopenia-related measures in men with prostate cancer previously or currently undergoing androgen deprivation therapy: An individual patient data meta-analysis.
Lopez P; Newton RU; Taaffe DR; Winters-Stone K; Galvão DA; Buffart LM
J Geriatr Oncol; 2023 Jun; 14(5):101535. PubMed ID: 37229882
[TBL] [Abstract][Full Text] [Related]
13. A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
Alibhai SM; Santa Mina D; Ritvo P; Sabiston C; Krahn M; Tomlinson G; Matthew A; Segal R; Warde P; Durbano S; O'Neill M; Culos-Reed N
BMC Cancer; 2015 Apr; 15():312. PubMed ID: 25908311
[TBL] [Abstract][Full Text] [Related]
14. Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial).
Galvão DA; Taaffe DR; Hayne D; Lopez P; Lyons-Wall P; Tang CI; Chambers SK; Devine A; Spry N; Jeffery E; Kudiarasu C; Joseph D; Newton RU
BMJ Open; 2022 Jun; 12(6):e058899. PubMed ID: 35667725
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Leslie WD; Lau YK
BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
[TBL] [Abstract][Full Text] [Related]
16. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.
Newton RU; Taaffe DR; Spry N; Gardiner RA; Levin G; Wall B; Joseph D; Chambers SK; Galvão DA
BMC Cancer; 2009 Jun; 9():210. PubMed ID: 19563641
[TBL] [Abstract][Full Text] [Related]
17. The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial.
Focht BC; Lucas AR; Grainger E; Simpson C; Thomas-Ahner JM; Clinton SK
Trials; 2014 Sep; 15():354. PubMed ID: 25199619
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
19. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]